Thermal balloon ablation in patients with multiple morbidity: 3-year follow-up.
OBJECTIVE
To evaluate the effectiveness of a thermal uterine balloon therapy system in a specific group of patients with multiple morbidity.


METHODS
Retrospective cohort analysis (Canadian Task Force classification II-2).


METHODS
Department of Obstetrics and Gynecology in two university teaching hospitals.


METHODS
Seventy women with severe systemic disease (American Association of Anesthesiologists physical status score >/= III) and severe menorrhagia.


METHODS
Uterine balloon therapy under local anesthesia and 3 years of follow-up.


RESULTS
The women had a mean age of 44.3 years (range, 24-76). After treatment, 25.7% of the patients had no bleeding, 45.7% hypomenorrhea, and 21.4% normal menstrual flow. The procedure was repeated successfully for one patient, and five failures (7.1%) were observed. The blood count values differed significantly (p <.001) before and after balloon therapy.


CONCLUSIONS
Uterine balloon therapy is a suitable and useful option for women with severe uterine bleeding and concomitant severe systemic nongynecologic disease.
Tóth
Dusan
D
Department of Obstetrics and Gynecology, 1st Medical Faculty, Charles University and General Faculty Hospital, Prague, Czech Republic.
Gervaise
Amelie
A
Kuzel
Daniel
D
Fernandez
Herve
H
D000328:Adult; D000368:Aged; D021721:Balloon Occlusion / Q000379:methods*; D002311:Cardiomyopathy, Dilated / Q000453:epidemiology; D017115:Catheter Ablation; D015331:Cohort Studies; D015897:Comorbidity; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006976:Hypertension, Pulmonary / Q000453:epidemiology; D008595:Menorrhagia / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D008875:Middle Aged; D009422:Nervous System Diseases / Q000453:epidemiology; D016377:Organ Transplantation; D012189:Retrospective Studies; D018570:Risk Assessment; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome